---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-067232"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2025-03-28T23:59:59+00:00"
generated_at: "2026-05-24T03:12:46.363381+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma closes ~$30.5M equity offering; issues 2.043M shares and pre-funded warrants

## Summary
- Gross proceeds ~$30.5M from underwritten offering of 1.143M shares + 300K pre-funded warrants at $13.00/$12.999 per share.
- Direct offering to Averill Master Fund and Averill Madison Master Fund of 900K shares at $13.00 per share.
- Post-closing: 25,546,288 common shares outstanding; warrants for 5,876,866 common shares and 15,270,807 pre-funded warrants.
- Pre-funded warrants have exercise price of $0.0001 per share.
- All securities sold in concurrent offerings at same price of $13.00 per share.

## SEC filing metadata
- accession: 0001193125-25-067232
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2025-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312525067232/0001193125-25-067232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312525067232/d831106d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-067232
- JSON: https://secwatch.observer/filing/0001193125-25-067232.json
- Plain text: https://secwatch.observer/filing/0001193125-25-067232.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.